Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.

Author: Conchon CostaAna Carolina, LaurettiGabriela Rocha, YamamotoPriscila Akemi, de MoraesNatália Valadares

Paper Details 
Original Abstract of the Article :
Pharmacogenomics (PGx) has emerged as an encouraging tool in chronic pain therapy. Genetic variations associated with drug effectiveness or adverse reactions (amitriptyline/nortriptyline/codeine/oxycodone/tramadol-CYP2D6, amitriptyline-CYP2C19, carbamazepine-HLA-A, carbamazepine/oxcarbazepine-HLA-B)...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2217/pgs-2019-0066

データ提供:米国国立医学図書館(NLM)

Unlocking the Secrets of Pharmacogenomics in Chronic Pain

Chronic pain, like a persistent desert wind, can have a devastating impact on individuals' lives. This study ventures into the fascinating realm of pharmacogenomics, exploring its potential to revolutionize the management of chronic pain. The researchers, like intrepid explorers, investigate the role of genetic variations in influencing the effectiveness and safety of pain medications, aiming to tailor treatment approaches for individual patients.

Pharmacogenomics: A New Compass in Chronic Pain Management

This research, like a map illuminating the intricate landscape of chronic pain, highlights the transformative potential of pharmacogenomics in guiding treatment decisions. The study unveils the influence of genetic variations on drug responses, emphasizing the importance of personalized medicine in chronic pain management. This discovery, like the discovery of a hidden oasis, offers a potential solution to the challenges of ineffective or adverse drug responses in individuals with chronic pain.

Personalized Pain Management: A Promise for Enhanced Outcomes

This study underscores the importance of personalized medicine in chronic pain management. The researchers' findings highlight the role of pharmacogenomics in tailoring treatment approaches to individual patients, potentially leading to improved drug effectiveness and reduced side effects. This research, like a camel caravan equipped with a new and improved compass, opens new doors for precision pain management, ultimately improving the lives of individuals living with chronic pain.

Dr.Camel's Conclusion

This study, like a desert oasis offering much-needed relief, presents a compelling case for the integration of pharmacogenomics into chronic pain management. The researchers have unearthed the power of genetic variations in influencing drug responses, paving the way for personalized treatment strategies that optimize outcomes for individuals with chronic pain. This research, a testament to the transformative potential of pharmacogenomics, promises a new era of precision pain management, offering hope and improved quality of life for those living with chronic pain.

Date :
  1. Date Completed 2020-06-01
  2. Date Revised 2020-06-01
Further Info :

Pubmed ID

31486733

DOI: Digital Object Identifier

10.2217/pgs-2019-0066

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.